-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Praxis Precision Medicine, Raises Price Target to $725

Benzinga·11/20/2026 17:43:02
Diffusion vocale
JP Morgan analyst Tessa Romero maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Overweight and raises the price target from $700 to $725.